Skip to main content
36°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
PepGen Inc. - Common Stock
(NQ:
PEPG
)
2.250
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PepGen Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
March 10, 2025
From
PepGen Inc.
Via
Business Wire
PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls
March 04, 2025
PepGen halts its Phase 2 CONNECT2 trial for PGN-EDO51 in DMD to assess 10 mg/kg cohort data, while advancing FREEDOM-DM1 studies in myotonic dystrophy.
Via
Benzinga
PepGen to Participate in Upcoming Investor Conferences
March 04, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
March 04, 2025
From
PepGen Inc.
Via
Business Wire
What's Driving the Market Sentiment Around PepGen?
February 25, 2025
Via
Benzinga
Why PepGen (PEPG) Stock Is Skyrocketing Today
February 24, 2025
PepGen shares are trading higher by 90% during Monday's session. The company announced early data from its FREEDOM-DM1 trial for myotonic dystrophy.
Via
Benzinga
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week
March 02, 2025
New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025.
Via
Stocktwits
These stocks have an unusual volume in today's session
February 28, 2025
Volume analysis on 2025-02-28: stocks with an unusual volume in today's session.
Via
Chartmill
PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz?
February 28, 2025
The rally follows PepGen's release of early clinical data from its Phase 1 trial evaluating its therapy to treat a rare genetic disorder.
Via
Stocktwits
These stocks are moving in today's after hours session
February 27, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Which stocks are experiencing notable movement on Thursday?
February 27, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
Which stocks are moving on Thursday?
February 27, 2025
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Top movers in Monday's session
February 24, 2025
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
These stocks are making the most noise in today's session.
February 24, 2025
Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today.
Via
Chartmill
These stocks are moving in today's session
February 24, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
February 24, 2025
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
February 24, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
February 24, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Announces CONNECT Program Updates
January 29, 2025
From
PepGen Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 16, 2024
Via
Benzinga
PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy
December 16, 2024
From
PepGen Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 03, 2024
Via
Benzinga
PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
November 21, 2024
From
PepGen Inc.
Via
Business Wire
Roku To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday
November 18, 2024
Via
Benzinga
PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 07, 2024
From
PepGen Inc.
Via
Business Wire
PepGen to Participate in Upcoming Investor Conferences
November 04, 2024
From
PepGen Inc.
Via
Business Wire
PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society
October 08, 2024
From
PepGen Inc.
Via
Business Wire
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
September 30, 2024
Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy
Via
MarketBeat
Exposures
Product Safety
PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors
September 19, 2024
From
PepGen Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.